Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma

BACKGROUND: Recent experience with thalidomide maintenance after high-dose chemotherapy with autologous stem cell support has demonstrated improvement in progression-free and overall survival. We further explored the tolerability and efficacy of lower doses of maintenance thalidomide in this single...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang, Julie E., Juckett, Mark B., Callander, Natalie S., Kahl, Brad S., Gangnon, Ronald E., Mitchell, Teri L., Longo, Walter L.
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913594/
https://ncbi.nlm.nih.gov/pubmed/18650178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLM.2008.n.018
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items